141 related articles for article (PubMed ID: 3909342)
21. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
Raz R; Flatau E; Sudarsky M; Keness J
Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
[TBL] [Abstract][Full Text] [Related]
22. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
23. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
24. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.
Cox CE
Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335
[TBL] [Abstract][Full Text] [Related]
25. Aztreonam.
Cunha BA
Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of aztreonam in the treatment of severe bacterial infections.
Romero-Vivas J; Rodríguez-Créixems M; Bouza E; Hellín T; Guerrero A; Martínez-Beltrán J; García de la Torre M
Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832
[TBL] [Abstract][Full Text] [Related]
28. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of aztreonam in infected patients.
Mattie H; Matze-van der Lans A
J Antimicrob Chemother; 1986 Feb; 17(2):215-9. PubMed ID: 3700287
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
Rodriguez JR; Ramirez-Ronda CH
Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
[TBL] [Abstract][Full Text] [Related]
31. Aztreonam.
Childs SJ; Bodey GP
Pharmacotherapy; 1986; 6(4):138-52. PubMed ID: 3534798
[TBL] [Abstract][Full Text] [Related]
32. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
33. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
Simons WJ; Lee TJ
Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
[TBL] [Abstract][Full Text] [Related]
34. Aztreonam: review of the clinical experience and potential uses in pediatrics.
Lebel MH; McCracken GH
Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
[No Abstract] [Full Text] [Related]
35. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
36. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
[TBL] [Abstract][Full Text] [Related]
37. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
[TBL] [Abstract][Full Text] [Related]
38. Clinical experience with aztreonam in the treatment of gram-negative bacteremia.
Scully BE; Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338
[TBL] [Abstract][Full Text] [Related]
39. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
Clergeot A; Steru D; Rosset MA; Carbon C
J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
